Showing results (781-790 of 2,510) with videos related to
Sort By:
Pageof 251
Journal of the International AIDS Society|October 22, 2011
Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan AfricaRichard G Wamai, Brian J Morris, Stefan A Bailis, et al.Journal of the International AIDS Society|August 17, 2011
Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational studyKarin van der Merwe, Risa Hoffman, Vivian Black, et al.Journal of the International AIDS Society|February 21, 2012
The ARV roll out and the disability grant: a South African dilemma?Marina Manuela de Paoli, Elizabeth Anne Mills, Arne Backer GrønningsaeterJournal of the International AIDS Society|February 21, 2012
A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatmentPaula Braitstein, Abraham Siika, Joseph Hogan, et al.Journal of the International AIDS Society|February 23, 2012
University students and HIV in Namibia: an HIV prevalence survey and a knowledge and attitude surveyIngrid H de Beer, Huub C Gelderblom, Onno Schellekens, et al.Journal of the International AIDS Society|January 31, 2012
Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South AfricaDeborah K Glencross, Lindi M Coetzee, Mamsallah Faal, et al.Journal of the International AIDS Society|November 8, 2014
The impact of SASA!, a community mobilization intervention, on reported HIV-related risk behaviours and relationship dynamics in Kampala, UgandaNambusi Kyegombe, Tanya Abramsky, Karen M Devries, et al.Journal of the International AIDS Society|November 14, 2014
From guidelines to action: implementation opportunities and realitiesWafaa El-SadrJournal of the International AIDS Society|November 14, 2014
Managing first-line failureDavid A CooperJournal of the International AIDS Society|November 14, 2014
Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGOJean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.Pageof 251